The Tri-Institutional MD-PhD Program (Tri-I), a Medical Scientist Training Program (MSTP), is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

On April 8th Weill Cornell Graduate School held the 40th Annual du Vigneaud Research Symposium, this year via remote webcast.The one day symposium featured two poster sessions and two sessions of oral presentations by current WCGS students, along with a keynote address by Dr. Kevan Shokat, of UCSF.
Dr. Katharine (Kathy) Hsu, MD, PhD (Tri-I graduating class of 1994) has been named as the new director of the Tri-Institutional MD-PhD Program. Dr. Hsu, currently a professor at Weill Cornell Graduate School of Medical Sciences and attending hemotologist and oncologist at Memorial Sloan Kettering Cancer Center, where she leads her lab in the study of the ability of natural killer (NK) cells to fight cancer.